🇺🇸 FDA
Patent

US 10023644

Antigen-binding proteins that activate the leptin receptor

granted A61KA61K2039/505A61K39/395

Quick answer

US patent 10023644 (Antigen-binding proteins that activate the leptin receptor) held by REGENERON PHARMACEUTICALS, INC. expires Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
REGENERON PHARMACEUTICALS, INC.
Grant date
Tue Jul 17 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 12 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
14
CPC classes
A61K, A61K2039/505, A61K39/395, A61P, A61P15/00